The expression of transforming growth factor β (TGF-β) and other immunosuppressive cytokines has been studied extensively as major immune modulators and as biomarkers for active TB and response to antimicrobial drug treatment [160–165]. This evidence concerns the gene TGFB1 and tuberculosis.